Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2003
07/16/2003EP1327447A1 Noribogaine in the treatment of pain and drug addiction
07/16/2003EP1327446A1 Controlled release oxycodone compositions
07/16/2003EP1327445A1 Controlled release oxycodone compositions
07/16/2003EP1327444A1 Antipruritic agent
07/16/2003EP1327443A1 Therapeutic or preventing agent for the diseases caused by a decrease in the expression level of the klotho protein
07/16/2003EP1327441A1 Chewing gum composition for eliminating nicotine, containing plant extracts and polyphenols such as catechin or quercetin
07/16/2003EP1327440A1 Oral preparations with favorable disintegration characteristics
07/16/2003EP1327434A1 Nanoemulsion comprising metabolites of ginseng saponin and a skin-care composition for anti-aging containing the same
07/16/2003EP1327149A2 Methods of high-throughput screening for internalizing antibodies
07/16/2003EP1327003A2 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
07/16/2003EP1326986A2 Regulation of human sphingosine kinase-like protein
07/16/2003EP1326981A2 Pharmaceutical preparations and methods for inhibiting tumors
07/16/2003EP1326971A2 Proteins and nucleic acids encoding same
07/16/2003EP1326969A2 Improved system for regulation of transgene expression
07/16/2003EP1326892A2 Compositions that inhibit proliferation of cancer cells
07/16/2003EP1326876A2 Anhydro sugar derivatives of indolocarbazoles
07/16/2003EP1326875A2 Tumor proliferation inhibitors
07/16/2003EP1326874A2 Topoisomerase inhibitors
07/16/2003EP1326873A1 Combinatorial libraries of monosaccharides
07/16/2003EP1326869A1 Pyrrole-condensed morphinoid derivatives
07/16/2003EP1326868A1 Morphinoid derivatives as delta-opioid agonists and antagonists
07/16/2003EP1326867A2 Bridged piperazine derivatives
07/16/2003EP1326866A1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines
07/16/2003EP1326865A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
07/16/2003EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
07/16/2003EP1326863A2 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
07/16/2003EP1326862A1 Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
07/16/2003EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
07/16/2003EP1326860A1 Quinazoline derivatives
07/16/2003EP1326859A1 Quinazoline derivatives with anti-tumour activity
07/16/2003EP1326858A2 Piperidine compounds as anti-allergic
07/16/2003EP1326857A2 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonists
07/16/2003EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
07/16/2003EP1326853A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
07/16/2003EP1326852A1 Aromatic and heterocyclic thiazolyl thiourea compounds and use
07/16/2003EP1326849A1 Benzodiazepine derivatives as inhibitors of gamma secretase
07/16/2003EP1326848A1 Dihydropyrimidine derivatives as cysteine protease inhibitors
07/16/2003EP1326847A1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use
07/16/2003EP1326845A1 N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent against parasitic protozoans
07/16/2003EP1326843A1 Pyrazole derivatives for the treatment of viral diseases
07/16/2003EP1326842A1 Arylpiperazine derivatives and their use as psychotropic agents
07/16/2003EP1326841A1 Pyridinone derivatives for treatment of atherosclerosis
07/16/2003EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326838A1 Novel crystalline forms of a factor xa inhibitor
07/16/2003EP1326837A1 Crystal forms of 1- 6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride
07/16/2003EP1326835A1 Benzamide compounds as apo b secretion inhibitors
07/16/2003EP1326834A2 2-substituted heterocyclic compounds
07/16/2003EP1326833A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326832A1 Chemical compounds
07/16/2003EP1326831A1 Substituted fused pyrroleimines and pyrazoleimines
07/16/2003EP1326828A1 Beta-amino acid derivatives as integrin receptor antagonists
07/16/2003EP1326826A1 Use of amino acids for treating pain
07/16/2003EP1326825A2 Compounds and compositions for delivering active agents
07/16/2003EP1326824A1 Pharmaceutical compounds
07/16/2003EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses
07/16/2003EP1326650A2 Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients
07/16/2003EP1326643A2 Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists
07/16/2003EP1326642A2 Catecholamine pharmaceutical compositions and methods
07/16/2003EP1326632A2 Agents for the treatment of viral infections
07/16/2003EP1326629A2 Methods and compositions for promoting the maturation of monocytes
07/16/2003EP1326627A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists
07/16/2003EP1326623A1 Saururus chinensis extract for prevention and treatment of neurodegenerative disease
07/16/2003EP1326622A1 Compositions and methods for treatment of multiple myeloma
07/16/2003EP1326620A1 S-adenosylmethionine and derivatives thereof for the treatment and prevention of alzheimer's disease
07/16/2003EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity
07/16/2003EP1326618A2 Use of aryl-substituted 1,1-diphosphonates for the treatment of bone diseases
07/16/2003EP1326617A1 Use of antiprogestins for the induction of apoptosis in a cell
07/16/2003EP1326616A1 New use of quetiapine
07/16/2003EP1326615A1 Phosphoric acid salt of an integrin receptor antagonist
07/16/2003EP1326613A1 Use of substituted imidazo 1,2-a]pyridine-, imidazo 1,2-a]pyrimidine and imidazo 1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments
07/16/2003EP1326612A1 Gatifloxacin pentahydrate
07/16/2003EP1326611A1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
07/16/2003EP1326610A2 Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
07/16/2003EP1326609A2 Stable oral formulation containing benzimidazole derivative
07/16/2003EP1326608A1 Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers
07/16/2003EP1326607A1 Pharmaceutical compositions containing oxapenem-3-carboxilic acids
07/16/2003EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/16/2003EP1326605A1 Methods for inhibiting proliferation and inducing apoptosis in cancer cells
07/16/2003EP1326604A2 Combination of at least two compounds selected from an at1-receptorantagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups
07/16/2003EP1326603A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension
07/16/2003EP1326602A1 Indole compounds as minimally physiologial function monitioring agents
07/16/2003EP1326601A2 The use of melatonin for induction of general anesthesia
07/16/2003EP1326600A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto
07/16/2003EP1326599A2 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin
07/16/2003EP1326598A1 Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
07/16/2003EP1326597A2 Methods for modulating bladder function
07/16/2003EP1326596A1 Pharmaceutical preparations containing a dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease
07/16/2003EP1326595A2 Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders
07/16/2003EP1326594A2 Ribavirin-pegylated interferon alfa hcv combination therapy
07/16/2003EP1326593A1 ESTROGEN RECEPTOR-$g(b) LIGANDS
07/16/2003EP1326592A1 Use of polyethylene glycol ( peg ) for the manufacture of a medicament for the treatment of constipation
07/16/2003EP1326591A2 Combination of statins and sorbitol dehydrogenase inhibitors
07/16/2003EP1326590A2 Patch comprising diclofenac
07/16/2003EP1326589A2 Nanoparticles
07/16/2003EP1326587A2 Hydrogel-driven drug dosage form
07/16/2003EP1326586A1 New pharmaceutical compositions containing epinastine and pseudoephedrine
07/16/2003EP1326585A2 Method for producing powdery formulations
07/16/2003EP1326583A1 Medication delivery devices
07/16/2003EP1326502A2 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate
07/16/2003EP1284733A4 Novel processes for preparing torsemide intermediate
1 ... 5406 5407 5408 5409 5410 5411 5412 5413 5414 5415 5416 5417 5418 5419 5420 5421 5422 5423 5424 5425 5426 ... 7860